Association of mitochondrial displacement loop polymorphisms with diarrhea-predominant irritable bowel syndrome: A preliminary study

被引:4
作者
Liu, Zi Yu [1 ]
Gua, Xia Xu [1 ]
Zhang, Rong Gui [1 ]
Wang, Xiao Xiao [1 ]
Ai, Jie [1 ]
Wang, Wei Feng [1 ,2 ]
Yang, Yun Sheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Shenzhen Univ, Div Gastroenterol & Hepatol, Hlth Sci Ctr, Shenzhen, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
diarrhea; DNA; irritable bowel syndrome; mitochondria; single nucleotide polymorphism; DNA POLYMORPHISMS; LEIGH-SYNDROME; CONTROL REGION; DISEASE; MTDNA; DISORDERS; MUTATION; ANTIDEPRESSANTS; POPULATION; LONGEVITY;
D O I
10.1111/1751-2980.12597
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVESTo investigate whether single nucleotide polymorphisms (SNPs) in the mitochondrial displacement loop (D-loop) were associated with irritable bowel syndrome (IBS). METHODSAltogether 40 participants were recruited and classified into three groups, including 20 that fulfilled the Rome III criteria for diarrhea-predominant IBS (IBS-D), 10 with constipation-predominant IBS (IBS-C), and 10 healthy volunteers (controls). DNA was extracted from biopsy specimens of the colon obtained during routine colonoscopies. The mitochondrial D-loop was sequenced and variants were identified in comparison with the reference sequence from GenBank. We searched GenBank and MITOMAP to determine whether a variant could be considered an SNP. RESULTSNo significant differences in sex, age and body mass index were found among the three groups. The average numbers of SNPs in the IBS-D, IBS-C and control groups were 12.22.7, 9.8 +/- 1.8 and 9.9 +/- 2.1, respectively. The frequency of SNPs was significantly higher in the IBS-D group than in the IBS-C group and controls (P < 0.05). No significant difference was found between the latter two groups. Each SNP was compared among the three groups and the frequency of 199C was found to be significantly higher in the control group than in the IBS-D group (P =0.03), but no significant difference in its frequency was found between the IBS-C group and controls. CONCLUSIONSPatients with IBS-D have a higher incidence of SNPs in the mitochondrial D-loop than controls. The genotype 199C may be associated with a lower risk of IBS-D.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [31] Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs
    Mozaffari, Shilan
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (03) : 219 - 228
  • [32] A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
    Chen, Chunqiu
    Tao, Chunhua
    Liu, Zhongchen
    Lu, Meiling
    Pan, Qiuhui
    Zheng, Lijun
    Li, Qing
    Song, Zhenshun
    Fichna, Jakub
    PHYTOTHERAPY RESEARCH, 2015, 29 (11) : 1822 - 1827
  • [33] WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier
    Li, Yaoguang
    Chen, Yangyang
    Liao, Zhengyue
    Liu, Yixin
    Liu, Chenhao
    Yang, Wenjing
    Bai, Jing
    Huang, Xinggui
    Hao, Yule
    Liu, Sijing
    Liu, Yi
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 334
  • [34] The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome
    Hod, Keren
    Dekel, Roy
    Cohen, Nathaniel Aviv
    Sperber, Ami
    Ron, Yishai
    Boaz, Mona
    Berliner, Shlomo
    Maharshak, Nitsan
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (12)
  • [35] Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome
    C. Subramanyam
    Nitesh Pratap
    Prasad Gandham
    Rupjyothi Talukdar
    M. Sasikala
    H. V. V. Murthy
    D. Nageshwar Reddy
    Indian Journal of Gastroenterology, 2015, 34 (3) : 275 - 276
  • [36] Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome
    Aggarwal, Surbhi
    Ahuja, Vineet
    Paul, Jaishree
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (03) : 422 - 430
  • [37] Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective
    Lewis, James H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (01) : 13 - 29
  • [38] Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes
    Bleser, Scott
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) : 503 - 512
  • [39] Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
    Mangel, Allen W.
    Hicks, Gareth A.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 1 - 10
  • [40] Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome
    Chang, Full-Young
    Lu, Ching-Liang
    Chen, Chih-Yen
    Luo, Jiing-Chyuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) : 2266 - 2272